The Carlyle Group Agrees to Acquire 30% Stake in Haier Bio-Medical and Laboratory Products Co., Ltd. for RMB405 Million

Investment Supports News Business and Global Expansion

Beijing, China - Global alternative asset manager The Carlyle Group (NASDAQ: CG) today announced that its RMB-denominated investment fund Carlyle Beijing Partners Fund, L.P. has agreed to acquire a 30% stake in Haier Bio-Medical and Laboratory Co., Ltd. (HBML) for RMB405 million (approximately $65 million). The RMB fund will have two board seats. The RMB fund was established by Carlyle Asia Partners advisory team with the support of the Beijing Municipal Government. 

A subsidiary of Haier Group, HBML is a developer and manufacturer of bio-medical and laboratory equipment for the Chinese and global markets. Its products and services include ultralow temperature freezers, medical fridges, biosafety hoods and storage safety solutions for its pharmacy, research lab, blood bank, corporate and other customers.

In 2011, Carlyle Asia Partners invested in Haier Electronics Group (01169.HK), another subsidiary of Haier Group, a global manufacturer of consumer electronics.

Janine Feng, Managing Director of The Carlyle Group, said, “We are pleased to deepen our relationship with Haier Group. Biomedical research and development is booming in China as its population matures and people’s livelihood improves. Through the investment in HBML, we expect to work closely with Haier Group, the company’s management team and other investors to support the company’s new business and global expansion by leveraging our global network and deep expertise in the healthcare industry.”

Carlyle was one of the first global private equity firms to establish a presence in China. It was also one of the first to have raised an RMB-denominated fund in the country. As of December 31, 2013, Carlyle has invested US$5.2 billion in about 80 transactions in China.

Carlyle has deep healthcare industry expertise and an extensive global healthcare portfolio. Its current and past investments include Meinian Onehealth Healthcare (Group) Co., the largest private provider of preventive healthcare check-up services in China; Concord Medical Service Co., the largest woundless medical service network in China; Healthscope Limited, the second largest private hospital provider in Australia; Integrated Dental Holdings and Associated Dental Practices, two major dental care providers in the U.K; Medical Park, a healthcare provider in Turkey; Qualicaps, a global supplier of capsules and equipment in Japan; and Global Health Private Limited, one of the largest hospital and healthcare providers in India. Most recently, Carlyle announced an agreement to acquire Johnson & Johnson’s Ortho-Clinical Diagnostics (OCD) business for $4.15 billion, which shares a similar distribution network and prospective customers with HBML, opening the door for potential future collaborations.

* * * * *

About The Carlyle Group
The Carlyle Group (NASDAQ: CG) is a global alternative asset manager with approximately $189 billion of assets under management across 118 funds and 106 fund of funds vehicles as of December 31, 2013. Carlyle’s purpose is to invest wisely and create value on behalf of its investors, many of whom are public pensions. Carlyle invests across four segments – Corporate Private Equity, Real Assets, Global Market Strategies and Solutions – in Africa, Asia, Australia, Europe, the Middle East, North America and South America. Carlyle has expertise in various industries, including: aerospace, defense & government services, consumer & retail, energy, financial services, healthcare, industrial, real estate, technology & business services, telecommunications & media and transportation. The Carlyle Group employs more than 1,500 people in 34 offices across six continents.

Web: www.carlyle.com 

Media contacts:

The Carlyle Group
Tammy Li                                                       Brian Zhou
Phone: +852 2878 5236                                Phone: +86 10 57067070
tammy.li@carlyle.com                                    brian.zhou@carlyle.com

# # #